|
⚲
|
| Keyboard |
| Daniel Spiegelman | |
|---|---|
| Firm | |
| Address | c/o Spruce Biosciences, Inc 611 Gateway Boulevard, Suite 740 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Spruce Biosciences Inc | 021-561207 | Director | 50.0 M of 50.0 M |
||
| Spruce Biosciences Inc | 021-474453 | Director | 53.6 M of 53.6 M |
||
| Oncothyreon Inc | 021-223047 | Director | 22.9 M of 22.9 M |
||
| Cyclacel Pharmaceuticals Inc | 021-177527 | Director | 3.0 M of 3.0 M |
||
| Jennerex Inc | 021-167195 | Director | 1.8 M of 1.8 M |
||
| Oncothyreon Inc | 021-155565 | Director | 0.1 M | ||
| Omeros Corp | 021-149626 | Director | of 12.0 M |
||
| Cyclacel Pharmaceuticals Inc | 021-149447 | Director | 15.2 M of 22.2 M |
||
| Oncothyreon Inc | 021-148655 | Director | 14.9 M of 28.3 M |
||
| Omeros Corp | 021-146406 | Director | of 40.0 M |
||
| Oncothyreon Inc | 021-144978 | Director | 0.2 M of 20.2 M |
||
| Affymax Inc | 021-55801 | Director | 42.0 M of 42.0 M |
||